We provide you with 20 years of free, institutional-grade data for EWTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EWTX. Explore the full financial landscape of EWTX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-07 | 1710072 | EWTX | 10-Q | Url |
| 2025-05-08 | 1710072 | EWTX | 10-Q | Url |
| 2025-03-03 | 1710072 | EWTX | 10-K | Url |
| 2024-11-07 | 1710072 | EWTX | 10-Q | Url |
| 2024-08-08 | 1710072 | EWTX | 10-Q | Url |
| 2024-05-09 | 1710072 | EWTX | 10-Q | Url |
| 2024-02-22 | 1710072 | EWTX | 10-K | Url |
| 2023-11-09 | 1710072 | EWTX | 10-Q | Url |
| 2023-08-10 | 1710072 | EWTX | 10-Q | Url |
| 2023-05-11 | 1710072 | EWTX | 10-Q | Url |
| 2023-02-23 | 1710072 | EWTX | 10-K | Url |
| 2022-11-03 | 1710072 | EWTX | 10-Q | Url |
| 2022-08-04 | 1710072 | EWTX | 10-Q | Url |
| 2022-05-11 | 1710072 | EWTX | 10-Q | Url |
| 2022-02-24 | 1710072 | EWTX | 10-K | Url |
| 2021-11-10 | 1710072 | EWTX | 10-Q | Url |
| 2021-08-09 | 1710072 | EWTX | 10-Q | Url |
| 2021-05-13 | 1710072 | EWTX | 10-Q | Url |
| 2021-03-05 | 1710072 | EWTX | S-1 | Url |
Edgewise Therapeutics, Inc(NASDAQ:EWTX) 
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The co...
Share this website to your friends
The information provided in this report about EWTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.